Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab

Development of effective therapies for recurrent glioblastoma multiforme (GBM) and reliable, timely evaluation of their benefit are needed. Understanding the relationship between objective response (OR) and survival is important for determining whether OR can provide an early signal of treatment act...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Prados, Michael, Cloughesy, Timothy, Samant, Meghna, Fang, Liang, Wen, Patrick Y., Mikkelsen, Tom, Schiff, David, Abrey, Lauren E., Yung, W.K. Alfred, Paleologos, Nina, Nicholas, Martin K., Jensen, Randy, Vredenburgh, James, Das, Asha, Friedman, Henry S.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2011
Assuntos:
Clinical Investigations
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3018914/
https://ncbi.nlm.nih.gov/pubmed/21084434
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq151
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados